- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: metformin,
Total 2492 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Italy, Russian Federation, Slovakia, Spain, Ireland, Germany, Turkey, Bulgaria, Hong Kong, Romania, South Africa
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
Handok Inc.UnknownType 2 Diabetes MellitusKorea, Republic of
-
Forest LaboratoriesPhenomixTerminatedDiabetes Mellitus, Type IIUnited States, Belarus, Colombia, Hungary, India, Lithuania, Peru, Romania
-
OPKO Health, Inc.CompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Romania, Poland, Mexico, Greece
-
Jinnah Postgraduate Medical CentreNot yet recruitingNon-Alcoholic Fatty Liver Disease | Type2diabetesPakistan
-
University of HawaiiWithdrawnHepatocellular CancerUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
RISE Study GroupNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Ohio State University Comprehensive Cancer CenterBayer; NovartisCompletedMelanoma | Renal CancerUnited States
-
Instituto do Cancer do Estado de São PauloCompletedPancreatic Adenocarcinoma Advanced or MetastaticBrazil
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
Seoul National University HospitalCompletedHuman MicrobiomeKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Canada, Germany, Netherlands, Argentina, Finland, Serbia, Mexico
-
PfizerCompletedDiabetes Mellitus, Type 2Taiwan, United States, Hungary, Canada, Slovakia, India, Bulgaria
-
NovartisCompletedDiabetes Mellitus, Type 2Germany, United States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, Italy, United States, Germany, United Kingdom, Russian Federation, Canada, Poland, Puerto Rico, Macedonia, The Former Yugoslav Republic of
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Handok Inc.Recruiting
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR); Sunnybrook Research InstituteRecruitingDiabetes Mellitus, Type 2 | Child Development | Child Obesity | Pregnancy in DiabeticCanada, Australia
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Completed
-
Air Force Military Medical University, ChinaUnknownHepatocellular CarcinomaChina
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Italy, United States, Germany, Canada, Puerto Rico
-
Novartis PharmaceuticalsCompletedType 2 Diabetes Mellitus (T2DM)Japan
-
TakedaCompleted
-
All India Institute of Medical Sciences, BhubaneswarNot yet recruitingDifference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia
-
Boehringer IngelheimCompleted
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; MultiVir, Inc.TerminatedSmall Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedJuvenile Myelomonocytic Leukemia | Recurrent Disease | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Childhood Solid Neoplasm | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia... and other conditionsUnited States, Canada
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
Sidney Kimmel Cancer Center at Thomas Jefferson...BayerCompletedBrain Metastases | Primary Brain TumorsUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Puerto Rico, Mexico
-
Mayo ClinicUniversity of IowaCompletedLymphoma | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, India
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Australia, United Kingdom, Mexico, Argentina, Brazil, Israel, Canada
-
AstraZenecaCompleted
-
SCRI Development Innovations, LLCBayer; NovartisCompletedKidney CancerUnited States
-
Sponsor GmbHiOMEDICO AGCompleted
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Hungary, Slovakia
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
AstraZenecaCompleted
-
VA Office of Research and DevelopmentNational Eye Institute (NEI); SmithKline BeechamCompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
Beijing Dongfang Biotech Co., Ltd.Not yet recruiting
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Taiwan, China, Mexico, Germany, Poland
-
SanofiCompleted